Analysis of awareness of Rapid Response Reports (RRRs)
| Do you recall having seen any of the following medication safety materials issued by the NPSA? | MD (n=46) | DN (n=39) | CG (n=40) | OD (n=38) | Total (n=167) |
| No (%) | No (%) | No (%) | No (%) | No (%) | |
| Cytarabine (2007) | 20 (43.5%) | 21 (53.8%) | 25 (62.5%) | 27 (71.1%) | 93 (57.1%) |
| Lipid and non-lipid amphotericin (2007) | 22 (47.8%) | 20 (51.3%) | 30 (75%) | 29 (76.3%) | 101 (62%) |
| Paraffin based skin products (2007) | 18 (39.1%) | 28 (71.8%) | 33 (82.5%) | 35 (92.1%) | 114 (69.9%) |
| Oral anti-cancer drugs (2008) | 31 (67.4%) | 24 (61.5%) | 31 (77.5%) | 36 (94.7%) | 122 (74.8%) |
| Intravenous heparin for flushing (2008) | 31 (67.4%) | 33 (84.6%) | 37 (92.5%) | 36 (94.7%) | 137 (84%) |
| Dosing errors in opioid medicines (2008) | 33 (71.7%) | 30 (76.9%) | 34 (85.0%) | 35 (92.1%) | 132 (81%) |
| Problems with infusions and sampling from arterial lines (2008) | 24 (52.2%) | 25 (64.1%) | 32 (80%) | 26 (68.4%) | 107 (65.6%) |
| Vinca alkaloid minibags (2008) | 26 (56.5%) | 25 (64.1%) | 32 (80%) | 30 (78.9%) | 113 (69.3%) |
| Administering Infanrix-IPV+Hib (2008) | 14 (30.4%) | 16 (41.0%) | 26 (65%) | 25 (65.8%) | 81 (49.7%) |
| Midazolam injections (2008) | 27 (58.7%) | 30 (76.9%) | 36 (90%) | 37 (97.4%) | 130 (79.8%) |
| Mean (%) | 53.5% | 64.6% | 79.0% | 83.2% | 67.7% |
MD, Medical Director; DN, Director of Nursing; CG, Clinical Governance Director; OD, other director.